XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 851,660 $ 21,952,000 $ 2,136 $ 36,843,326 $ (48,495,076) $ 11,154,046
Balance (in Shares) at Dec. 31, 2020 170,332 21,952 21,359,945      
Provision for compensation expense related to stock-based compensation 1,125,819 1,125,819
Issuance of warrants in connection with consulting agreements 522,808   522,808
Exercise of stock options into common stock $ 8 68,164 68,172
Exercise of stock options into common stock (in Shares) 82,333      
Net income 3,272,774 3,272,774
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 38,560,117 (45,222,302) 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278      
Provision for compensation expense related to stock-based compensation 997,830 997,830
Exercise of stock options into common stock $ 32 261,473 261,505
Exercise of stock options into common stock (in Shares) 308,526      
Net income 13,631,719 13,631,719
Balance at Dec. 31, 2022 $ 851,660 $ 21,952,000 $ 2,176 $ 39,819,420 $ (31,590,583) $ 31,034,673
Balance (in Shares) at Dec. 31, 2022 170,332 21,952 21,750,804